First test of new drug in healthy women
NCT ID NCT06908707
Summary
This was an early-stage study to check the safety of a new drug called LAE102 and see how the body processes it. It involved 32 healthy women who had gone through menopause. Participants received a single dose of either the drug or a placebo, and researchers monitored them for side effects and measured drug levels in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Trials
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.